Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1994 Sep;38(3):278–281. doi: 10.1111/j.1365-2125.1994.tb04354.x

The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria.

K Na-Bangchang 1, L Limpaibul 1, A Thanavibul 1, P Tan-Ariya 1, J Karbwang 1
PMCID: PMC1364802  PMID: 7826832

Abstract

The pharmacokinetics of chloroquine (CQ) and desethylchloroquine (DECQ) were studied in seven male Thai patients with P. vivax malaria and seven healthy male Thais, after the standard oral dosage regimen of CQ (a total dose of 1500 mg given over 3 days). All patients showed a rapid initial response to the treatment with median (range) values of fever and parasite clearance times of 13.7 (2-47) and 58 (33-38) h, respectively. In the patients, the median range Cmax value was significantly higher (1547 (996-2446) vs 838 (656-1587) ng ml-1), and AUC(0,28d) was greater (281 (250-515) vs 122 (103-182) micrograms ml-1 h). In addition, the median (AUC(0,28d) of DECQ was significantly greater (170 (72-265) vs 77 (49-140) micrograms ml-1 h). The AUC(0,28d) ratio of DECQ to CQ in patients was significantly higher than that in healthy subjects (0.67 (0.43-0.90) vs 0.51 (0.29-0.61)).

Full text

PDF
278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alván G., Ekman L., Lindström B. Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography. J Chromatogr. 1982 Apr 16;229(1):241–247. doi: 10.1016/s0378-4347(00)86059-4. [DOI] [PubMed] [Google Scholar]
  2. Baird J. K., Basri H., Purnomo, Bangs M. J., Subianto B., Patchen L. C., Hoffman S. L. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1991 May;44(5):547–552. doi: 10.4269/ajtmh.1991.44.547. [DOI] [PubMed] [Google Scholar]
  3. Bergqvist Y., Domeij-Nyberg B. Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr. 1983 Jan 14;272(1):137–148. doi: 10.1016/s0378-4347(00)86110-1. [DOI] [PubMed] [Google Scholar]
  4. Brockelman C. R., Tan-Ariya P., Bunnag D. Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine. Southeast Asian J Trop Med Public Health. 1989 Mar;20(1):41–47. [PubMed] [Google Scholar]
  5. Edwards G., Looareesuwan S., Davies A. J., Wattanagoon Y., Phillips R. E., Warrell D. A. Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol. 1988 Apr;25(4):477–485. doi: 10.1111/j.1365-2125.1988.tb03332.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gustafsson L. L., Rombo L., Alván G., Björkman A., Lind M., Walker O. On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther. 1983 Sep;34(3):383–385. doi: 10.1038/clpt.1983.183. [DOI] [PubMed] [Google Scholar]
  7. Rieckmann K. H., Davis D. R., Hutton D. C. Plasmodium vivax resistance to chloroquine? Lancet. 1989 Nov 18;2(8673):1183–1184. doi: 10.1016/s0140-6736(89)91792-3. [DOI] [PubMed] [Google Scholar]
  8. Schuurkamp G. J., Spicer P. E., Kereu R. K., Bulungol P. K. A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report. Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):607–608. doi: 10.1016/0035-9203(89)90370-2. [DOI] [PubMed] [Google Scholar]
  9. Schuurkamp G. J., Spicer P. E., Kereu R. K., Bulungol P. K., Rieckmann K. H. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg. 1992 Mar-Apr;86(2):121–122. doi: 10.1016/0035-9203(92)90531-g. [DOI] [PubMed] [Google Scholar]
  10. Schwartz I. K., Lackritz E. M., Patchen L. C. Chloroquine-resistant Plasmodium vivax from Indonesia. N Engl J Med. 1991 Mar 28;324(13):927–927. doi: 10.1056/NEJM199103283241317. [DOI] [PubMed] [Google Scholar]
  11. Tett S. E., Cutler D. J., Day R. O. Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques. J Pharm Sci. 1992 Feb;81(2):155–159. doi: 10.1002/jps.2600810211. [DOI] [PubMed] [Google Scholar]
  12. Whitby M., Wood G., Veenendaal J. R., Rieckmann K. Chloroquine-resistant Plasmodium vivax. Lancet. 1989 Dec 9;2(8676):1395–1395. doi: 10.1016/s0140-6736(89)92002-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES